235 related articles for article (PubMed ID: 25959355)
1. Different risk factor profiles distinguish early-onset from late-onset BKV-replication.
Schachtner T; Babel N; Reinke P
Transpl Int; 2015 Sep; 28(9):1081-91. PubMed ID: 25959355
[TBL] [Abstract][Full Text] [Related]
2. Simultaneous pancreas/kidney transplant recipients present with late-onset BK polyomavirus-associated nephropathy.
Schachtner T; Zaks M; Kahl A; Reinke P
Nephrol Dial Transplant; 2016 Jul; 31(7):1174-82. PubMed ID: 26758790
[TBL] [Abstract][Full Text] [Related]
3. Reactivation of BK Virus in the Early Period After Kidney Transplantation.
Ziedina I; Folkmane I; Chapenko S; Murovska M; Sultanova A; Jushinskis J; Rozental R
Transplant Proc; 2009 Mar; 41(2):766-8. PubMed ID: 19328975
[TBL] [Abstract][Full Text] [Related]
4. BK virus nephropathy in renal transplant recipients in Kuwait: a preliminary report.
Nampoory MR; Johny KV; Pacsa A; Nair PM; Said T; Halim MA; Francis I; Samhan M; Mousawi M; Dalawi A; Szucs G; Al-Nakib W
Transplant Proc; 2005 Sep; 37(7):3048-50. PubMed ID: 16213300
[TBL] [Abstract][Full Text] [Related]
5. Results of repeat renal transplantation after graft loss from BK virus nephropathy.
Geetha D; Sozio SM; Ghanta M; Josephson M; Shapiro R; Dadhania D; Hariharan S
Transplantation; 2011 Oct; 92(7):781-6. PubMed ID: 21836535
[TBL] [Abstract][Full Text] [Related]
6. Inflammatory activation and recovering BKV-specific immunity correlate with self-limited BKV replication after renal transplantation.
Schachtner T; Stein M; Sefrin A; Babel N; Reinke P
Transpl Int; 2014 Mar; 27(3):290-301. PubMed ID: 24279642
[TBL] [Abstract][Full Text] [Related]
7. CMV Viremia is associated with a decreased incidence of BKV reactivation after kidney and kidney-pancreas transplantation.
Elfadawy N; Flechner SM; Liu X; Schold J; Srinivas TR; Poggio E; Fatica R; Avery R; Mossad SB
Transplantation; 2013 Dec; 96(12):1097-103. PubMed ID: 24056621
[TBL] [Abstract][Full Text] [Related]
8. Factors and outcome in BK virus nephropathy in a Hispanic kidney transplant population.
Pérez-Torres D; Bertrán-Pasarell J; Santiago-Delpín E; González-Ramos M; Medina-Mangual S; Morales-Otero L; González-Caraballo Z
Transpl Infect Dis; 2010 Feb; 12(1):16-22. PubMed ID: 19804584
[TBL] [Abstract][Full Text] [Related]
9. Prospective study of polyomavirus type BK replication and nephropathy in renal-transplant recipients.
Hirsch HH; Knowles W; Dickenmann M; Passweg J; Klimkait T; Mihatsch MJ; Steiger J
N Engl J Med; 2002 Aug; 347(7):488-96. PubMed ID: 12181403
[TBL] [Abstract][Full Text] [Related]
10. Prospective monitoring of BK virus replication in renal transplant recipients.
Koukoulaki M; Grispou E; Pistolas D; Balaska K; Apostolou T; Anagnostopoulou M; Tseleni-Kotsovili A; Hadjiconstantinou V; Paniara O; Saroglou G; Legakis N; Drakopoulos S
Transpl Infect Dis; 2009 Feb; 11(1):1-10. PubMed ID: 18811631
[TBL] [Abstract][Full Text] [Related]
11. ABO desensitization affects cellular immunity and infection control after renal transplantation.
Schachtner T; Stein M; Reinke P
Transpl Int; 2015 Oct; 28(10):1179-94. PubMed ID: 26033637
[TBL] [Abstract][Full Text] [Related]
12. Ciprofloxacin prophylaxis in kidney transplant recipients reduces BK virus infection at 3 months but not at 1 year.
Wojciechowski D; Chanda R; Chandran S; Lee B; Webber A; Macaraig M; Tomlanovich S; Vincenti F
Transplantation; 2012 Dec; 94(11):1117-23. PubMed ID: 23060281
[TBL] [Abstract][Full Text] [Related]
13. Early BK polyomavirus (BKV) reactivation in donor kidney is a risk factor for development of BKV-associated nephropathy.
Saundh BK; Baker R; Harris M; Welberry Smith MP; Cherukuri A; Hale A
J Infect Dis; 2013 Jan; 207(1):137-41. PubMed ID: 23100561
[TBL] [Abstract][Full Text] [Related]
14. Nucleic Acid Tests for BK Polyomavirus Is Critical in Renal Transplant Recipients.
Chang YL; Cheng YT; Chen TC; Chien YS; Lee WC; Shen YC
Transplant Proc; 2018 Oct; 50(8):2489-2492. PubMed ID: 30316383
[TBL] [Abstract][Full Text] [Related]
15. Unusual presentations of BK virus infections in pediatric renal transplant recipients.
Drake KA; Najera L; Reed RC; Verghese PS
Pediatr Transplant; 2013 Feb; 17(1):E9-15. PubMed ID: 23171066
[TBL] [Abstract][Full Text] [Related]
16. Adverse impact of pretransplant polyoma virus infection on renal allograft function.
Hayat A; Mukhopadhyay R; Radhika S; Sachdeva MS; Nada R; Joshi K; Sakhuja V; Jha V
Nephrology (Carlton); 2008 Apr; 13(2):157-63. PubMed ID: 18275505
[TBL] [Abstract][Full Text] [Related]
17. Everolimus leads to a lower risk of BKV viremia than mycophenolic acid in de novo renal transplantation patients: a single-center experience.
Moscarelli L; Caroti L; Antognoli G; Zanazzi M; Di Maria L; Carta P; Minetti E
Clin Transplant; 2013; 27(4):546-54. PubMed ID: 23758330
[TBL] [Abstract][Full Text] [Related]
18. BK virus nephropathy: clinical experience in a university hospital in Japan.
Takayama T; Ito T; Suzuki K; Ushiyama T; Horii T; Miura K; Ozono S
Int J Urol; 2009 Dec; 16(12):924-8. PubMed ID: 19832926
[TBL] [Abstract][Full Text] [Related]
19. BK virus infection in transplant recipients: clinical manifestations, treatment options and the immune response.
van Aalderen MC; Heutinck KM; Huisman C; ten Berge IJ
Neth J Med; 2012 May; 70(4):172-83. PubMed ID: 22641625
[TBL] [Abstract][Full Text] [Related]
20. Observations on the use of cidofovir for BK virus infection in renal transplantation.
Kuten SA; Patel SJ; Knight RJ; Gaber LW; DeVos JM; Gaber AO
Transpl Infect Dis; 2014 Dec; 16(6):975-83. PubMed ID: 25412701
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
